- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/48 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
Patent holdings for IPC class A61K 47/48
Total number of patents in this class: 8504
10-year publication summary
|
1804
|
496
|
118
|
57
|
44
|
34
|
13
|
2
|
0
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Nektar Therapeutics | 437 |
155 |
| The Regents of the University of California | 20137 |
118 |
| Genentech, Inc. | 4012 |
87 |
| Massachusetts Institute of Technology | 10117 |
82 |
| F. Hoffmann-La Roche AG | 7947 |
74 |
| The Johns Hopkins University | 5723 |
64 |
| ImmunoGen, Inc. | 401 |
63 |
| Novo Nordisk A/S | 2279 |
60 |
| Novartis AG | 10709 |
58 |
| Centre National de La Recherche Scientifique | 10576 |
52 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2882 |
52 |
| MedImmune Limited | 621 |
50 |
| Bristol-myers Squibb Company | 4850 |
47 |
| Allergan, Inc. | 2334 |
46 |
| Board of Regents, The University of Texas System | 5884 |
45 |
| Immunomedics, Inc. | 261 |
42 |
| Pfizer Inc. | 3391 |
41 |
| SeaGen Inc | 594 |
37 |
| The Brigham and Women's Hospital, Inc. | 2217 |
36 |
| Ascendis Pharma A/S | 183 |
36 |
| Other owners | 7259 |